SGO From a Distance

Due to family commitments I was unable to attend this year's SGO Annual Meeting in Chicago. I did though follow a number of advocates and physicians who were tweeting live from the event. Here are some of the high points of the sessions from Saturday and Sunday.

Dr. Barakat announces 2 milestones: 2,000 members & 2,000 attendees #SGO2015 pic.twitter.com/XIAdE1imwW
— SGO (@SGO_org) March 28, 2015

#SGO2015 Over 80% of cancer care in US delivered by community oncologists. "We need to enhance access to clinical trials in the community."
— SGO (@SGO_org) March 29, 2015

Ovarian Cancer:

#sgo2015 MEK inhibitor toxicities may limit long term use in patients with low-grade serous ovarian cancer.
— Eijean Wu, MD (@eijeanMD) March 27, 2015

Excellent presentation on genetic basis of ovarian ca #SGO2015 pic.twitter.com/SUcZQZ5Eg0
— Nadeem R. Abu-Rustum (@aburustummd) March 28, 2015

Genetic Testing for Gynecologic Cancer, What You Need to Know @SGO_org @Pathologists #SGO2015 #gyncsm https://t.co/hoEcTbqISV
— Michael Misialek, MD (@DrMisialek) March 28, 2015

Check out Rob Coleman's video on highlights of 213 https://t.co/celCb2MvwZ #SGO2015
— Barbara Goff (@goffsgo) March 29, 2015

#SGO2015 conclusion Dr Ian Jacobs on ovarian ca screening. pic.twitter.com/fIjHDynuvl
— Nadeem R. Abu-Rustum (@aburustummd) March 29, 2015

@womenofteal @drdonsdizon RANDOMIZED PHASE 2 EVALUATION OF BEVACIZUMAB VERSUS BEVACIZUMAB/FOSBRETABULIN IN RECURRENT OVARIAN, TUBAL OR PP
— Annie Ellis (@Stigetta) March 29, 2015

Clinical Trials:

@ShannonWestin @erinstevensmd @drdonsdizon SGO statement on clinical trial endpoints https://t.co/LfrpCLQJHZ #SGO2015
— Jen Burzawa (@jburzawa) March 28, 2015

Vaccines:

"@TargetedOnc: FANG Vaccine Markedly Decreases Disease Recurrence in Phase II Ovarian Cancer Trial http://t.co/cgDyYXBgvk #sgo2015"
— Don S Dizon (@drdonsdizon) March 29, 2015

Gradalis FANG™ Tumor Vaccine Stimulates Immune Response and Doubles PFS  in  Advanced Ovarian Cancer | @scoopit http://t.co/kYvQ6wFjgt
— Krishan Maggon (@kkmaggon) June 20, 2014

 Genetics/ BRCA Mutations:

#SGO2015 Ian Jacobs. Most BRCA mutation carriers don't have a family hx of cancer pic.twitter.com/M0Sp798Tqw
— Jurgen Piek (@JurgenPiek) March 29, 2015

Sad Sobering Statistic: Nearly HALF of all women w/ #ovariancancer & #BRCA mutation have no history of HBOC cancers. #SGO2015 #mustDobetter
— Lisa M Guzzardi, RN (@LguzzardiM) March 29, 2015

Risk Reducing Surgery:

Love actionable slides! #SGO2015 pic.twitter.com/zwM7QFBz9t
— Jeff F. Lin (@JeffLinMD) March 29, 2015

HPV:

@aburustummd #SGO2015 conclusions from HPV 9 presentation Dr Joura pic.twitter.com/mutMtjRkCY #gyncsm #HPV #Cervicalcancer
— Women of Teal (@womenofteal) March 29, 2015

Exercise:

#SGO2015 Poster: Survival of the fittest: can exercise prolong time to ovca recurrence? M Onstad MDAnderson #gyncsm pic.twitter.com/jcZsaFRLYL
— Annie Ellis (@Stigetta) March 29, 2015

I certainly appreciate the efforts of those attending the meeting to let us at home be on top of the latest research in gynecologic cancers.

Dee
Every Day is a blessing!